Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
27.55
-0.30 (-1.08%)
At close: May 9, 2025, 4:00 PM
27.55
0.00 (0.00%)
After-hours: May 9, 2025, 7:59 PM EDT

Viking Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3,0944,4841,862721360411
Upgrade
Market Cap Growth
-69.77%140.89%158.23%100.31%-12.38%-29.13%
Upgrade
Enterprise Value
2,2433,5551,487567144156
Upgrade
Last Close Price
27.5540.2418.619.404.605.63
Upgrade
PB Ratio
3.655.095.344.961.781.68
Upgrade
P/TBV Ratio
3.655.095.344.961.781.68
Upgrade
Debt / Equity Ratio
0.000.000.000.0100.00
Upgrade
Quick Ratio
43.5232.9318.927.0923.0220.48
Upgrade
Current Ratio
44.2533.0919.197.6123.9821.12
Upgrade
Return on Equity (ROE)
-14.40%-17.90%-34.79%-39.67%-24.65%-15.15%
Upgrade
Return on Assets (ROA)
-11.74%-14.77%-23.47%-23.19%-14.90%-9.86%
Upgrade
Return on Capital (ROIC)
-12.08%-15.32%-25.38%-25.21%-15.58%-10.21%
Upgrade
Earnings Yield
-4.14%-2.45%-4.61%-9.55%-15.28%-9.62%
Upgrade
Buyback Yield / Dilution
-10.50%-15.57%-22.79%0.47%-6.34%-0.89%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q